Evidence map›Paper›PMID 33510463›Full record

ArticleNature immunology2021

IRGM1 links mitochondrial quality control to autoimmunity.

Prashant Rai, Kyathanahalli S Janardhan, Julie Meacham, Jennifer H Madenspacher, Wan-Chi Lin, Peer W F Karmaus, Jennifer Martinez, Quan-Zhen Li, Mei Yan, Jialiu Zeng and 4 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 1 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 1 synthesis or guideline pooled it, 116 citations in OpenAlex.

  1. Pooled it
  2. Autophagy modulation in cancer.Nature reviews. Drug discovery · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. METTL14-dependent mbioRxiv : the preprint server for biology · 2026
    Article
  13. Irgm1 Restrains CD8European journal of immunology · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Tissue Immunometabolism in Autoimmunity.European journal of immunology · 2026
    Review
  20. Review

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Prashant RaiImmunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA. prashant.rai@nih.gov.ORCID http://orcid.org/0000-0003-0258-4567
Kyathanahalli S JanardhanCellular & Molecular Pathology Branch, National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.
Julie MeachamImmunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA.
Jennifer H MadenspacherImmunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA.
Wan-Chi LinImmunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA.
Peer W F KarmausImmunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA.
Jennifer MartinezImmunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA.
Quan-Zhen LiDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Mei YanDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Jialiu ZengDepartment of Biomedical Engineering, Boston University, Boston, MA, USA.ORCID http://orcid.org/0000-0001-7802-1432
Mark W GrinstaffDepartment of Biomedical Engineering, Boston University, Boston, MA, USA.
Orian S ShirihaiDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-8466-3431
Gregory A TaylorDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC, USA.
Michael B FesslerImmunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA. fesslerm@niehs.nih.gov.ORCID http://orcid.org/0000-0002-8262-8613
National Institute of Environmental Health Sciences · USBoston University · USThe University of Texas Southwestern Medical Center · USDuke University · USUniversity of California, Los Angeles · US

Funding

Molecular Genetics Support to Identify Gene/Environment Interactions in DiseaseZICES102546 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI GERRISH, KEVIN · 2009 to 2025
$30.5M
Characterization of the molecular mechanisms of LC3-associated phagocytosis and its role in disease pathogenesisZIAES103286 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI MARTINEZ, JENNIFER · 2015 to 2021
$9.2M
Cell Signaling of Host DefenseZ01ES102005 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI FESSLER, MICHAEL B · 2006 to 2008
$3.3M
IRGM proteins as regulators of inflammationR01AI148243 · NIAID · DUKE UNIVERSITY · PI COERS, JOERN, TAYLOR, GREGORY A · 2020 to 2024
$2.4M
Role of IRGM proteins in immunity to enteric bacteriaR01AI145929 · NIAID · DUKE UNIVERSITY · PI TAYLOR, GREGORY A · 2019 to 2023
$1.6M
R21: Acidic Nanoparticles for Restoration of Autophagy in Age-associated NAFLDR21AG063373 · NIA · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI GRINSTAFF, MARK W., SHIRIHAI, ORIAN S · 2019 to 2020
$458k
A novel approach for reversal of autophagic defects using lysosome-targeted nanoparticlesR21AG060456 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GRINSTAFF, MARK W., SHIRIHAI, ORIAN S · 2019 to 2020
$455k
Regulation of T cell metabolism and function by IRGM proteinsR21AI135398 · NIAID · DUKE UNIVERSITY · PI MACIVER, NANCIE, TAYLOR, GREGORY A · 2019 to 2020
$442k
Intramural NIH HHS Z01 ES102005Intramural NIH HHS ZIA ES103286NIAID NIH HHS R01 AI145929NIAID NIH HHS R01 AI148243NIAID NIH HHS R21 AI135398NIA NIH HHS R21 AG060456NIA NIH HHS R21 AG063373
6 · The paper itself

Abstract

Mitochondrial abnormalities have been noted in lupus, but the causes and consequences remain obscure. Autophagy-related genes ATG5, ATG7 and IRGM have been previously implicated in autoimmune disease. We reasoned that failure to clear defective mitochondria via mitophagy might be a foundational driver in autoimmunity by licensing mitochondrial DNA-dependent induction of type I interferon. Here, we show that mice lacking the GTPase IRGM1 (IRGM homolog) exhibited a type I interferonopathy with autoimmune features. Irgm1 deletion impaired the execution of mitophagy with cell-specific consequences. In fibroblasts, mitochondrial DNA soiling of the cytosol induced cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING)-dependent type I interferon, whereas in macrophages, lysosomal Toll-like receptor 7 was activated. In vivo, Irgm1

Indexed as

AutoimmunityMitophagyAnimalsAutoimmune DiseasesCells, CulturedCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseFibroblastsGene Expression RegulationGTP-Binding ProteinsMacrophagesMembrane GlycoproteinsMembrane ProteinsMiceMice, Inbred C57BLMitochondriaNucleotidyltransferasescGAS protein, mouseCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseGTP-Binding ProteinsIfi1 protein, mouseMembrane GlycoproteinsMembrane ProteinsNucleotidyltransferasesSting1 protein, mouseSTING ProteinTlr7 protein, mouseToll-Like Receptor 7

Identifiers

PMID33510463
PMCPMC7906953
OpenAlexW3123202464

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.